Here are three fantastic biotech stocks harnessing the power of AI that could make a great addition to your portfolio. The ...

VAX-31’s safety, tolerability, and immunogenicity are being assessed in this trial on healthy infants. Vaxcyte anticipat ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A new bridge over the Fox River is slated for completion by 2030. Designers are still determining the future bridge's ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

Financial GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs 05.02.2025 / 15:06 CET/CEST The issuer is solely responsible for the content of this ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

The city of High Point is advancing its plans to replace a major piece of infrastructure at one of its water-supply lakes. The City Council on Monday approved a request from staff to award a $3.73 ...